Co-localization of tryptase and cathepsin-G in mast cells in cutaneous mastocytosis

Cancer Letters

Volumn 279, Issue 2, 2009, Pages 209-212

  Ribatti, D ^a   Nico, B ^a   Finato, N ^b   Crivellato, E ^b   Beltrami, C A ^b  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Cathepsin G; Cutaneous mastocytosis; Mast cells; Tryptase

Indexed keywords

ANTIBODY; CATHEPSIN G; TRYPTASE;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAST CELL; MORPHOMETRICS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SECRETORY GRANULE; SKIN BIOPSY; URTICARIA PIGMENTOSA;

BIOLOGICAL MARKERS; CATHEPSINS; HUMANS; MAST CELLS; MASTOCYTOSIS, CUTANEOUS; SERINE ENDOPEPTIDASES; SKIN; TRYPTASES;

EID: 67349138673     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.01.039     Document Type: Article

References (22)

1. Valent P., Horny H.P., Escribano L., Longley B.J., Li C.Y., Schwartz L.B., Marone G., Nunez R., Akin C., Sotlar K., Sperr W.R., Wolff K., Brunning R.D., Parwaresch R.M., Austen K.F., Lennert K., Metcalfe D.D., Vardiman J.W., and Bennett J.M. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leukemia Res. 25 (2001) 603-625
2. Hartmann K., and Henz B.M. Mastocytosis: recent advances in defining the disease. Br. J. Dermatol. 144 (2001) 682-695
3. Castells M., and Austen K.F. Mastocytosis: mediator-related signs and symptoms. Int. Arch. Allergy Immunol. 127 (2002) 147-152
4. Brockow K K., and Metcalfe D.D. Mastocytosis. Curr. Opin. Allergy Clin. Immunol. 1 (2001) 449-454
5. Irani A.A., Schechter N.M., Craig S.S., De Blois G., and Schwartz L.B. Two types of human mast cells that have distinct neutral protease composition. Proc. Natl. Acad. Sci USA 83 (1986) 4464-4468
6. Schwartz L.B. Analysis of MC(T) and MC(TC) mast cells in tissue. Methods Mol. Biol. 315 (2006) 53-62
7. Helske S., Syvaranta S., Kupari M., Lappalainen J., Oorni K., and Mayaranpaa M.I. Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves. Eur. Heart J. 27 (2006) 1495-1504
8. Zhao W., Oskeritzian C.A., Pozez A.L., and Schwartz L.B. Cytokine production by skin-derived mast cells: endogenous proteases are responsible for degradation of cytokines. J. Immunol. 175 (2005) 2635-2642
9. Irani A.A., Garriga M.M., Metcalfe D.D., and Schwartz L.B. Mast cells in cutaneous mastocytosis: accumulation of the MCYC type. Clin. Exp. Allergy 20 (1990) 53-58
10. Horny H.P., Sillaber C., Menke D., Kaiserling E., Wehrmann M., and Stebberger B. Diagnostic utility of staining for tryptase in patients with mastocytosis. Am. J. Surg. Pathol. 2 (1998) 1132-1140
11. Sperr W.R., Jordan J.H., Fiegl M., Escribano L., Bellas C., Dirnhofer S., Semper H., Simonitsch-Klupp I I., Horny H.P., and Valent P. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease. Int. Arch. Allergy. Clin. Immunol. 128 (2002) 136-141
12. Blair R.J., Meng H., Marchese M.J., Ren S., Schwartz L.B., Tonnese M.G., and Gruber B.L. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J. Clin. Invest. 99 (1997) 2691-2700
13. Ribatti D., Vacca A., Nico B., Quondamatteo F., Ria R., Minischetti M., Marzullo A., Herken R., Roncali L., and Dammacco F. Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Brit. J. Cancer. 79 (1999) 451-455
14. Ribatti D., Vacca A., Marzullo A., Nico B., Ria R., Roncali L., and Dammacco F. Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell Non-Hodgkin's lymphomas. Int. J. Cancer 85 (2000) 171-175
15. Ribatti D., Polimeno G., Vacca A., Marzullo A., Crivellato E., Nico B., Lucarelli G., and Dammacco F. Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes. Leukemia 16 (2002) 1680-1684
16. Ribatti D., Molica S., Vacca A., Nico B., Crivellato E., Roccaro A.R., and Dammacco F. Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia 17 (2003) 1428-1430
17. Ribatti D., Vacca A., Ria R., Marzullo A., Nico B., Filotico R., Roncali L., and Dammacco F. Neovascularization, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur. J. Cancer. 39 (2003) 666-674
18. Ribatti D., Ennas M.G., Vacca A., Ferreli F., Nico B., Orru S., and Sirigu P. Tumor vascularity and tryptase positive-mast cells correlate with a poor prognosis in melanoma. Eur. J. Clin. Invest. 33 (2003) 420-425
19. Ribatti D., Finato N., Crivellato E., Marzullo A., Mangieri D., Nico B., Vacca A., and Beltrami C.A. Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. Am. J. Obstet. Gynecol. 193 (2005) 1961-1965
20. Reilly C.F., Tewksbury D.A., Schechter N.M., and Travis J. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cells proteinases. J. Biol. Chem. 257 (1982) 8619-8622
21. Fernandez L.A., Twickler J., and Mead A. Neovascularization produced by angiotensin II. J. Lab. Clin. Med. 105 (1985) 141-145
22. Williams B., Backer A.Q., Gallacher B., and Lodwick D. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension 25 (1995) 913-917